In Medscape: When it comes to clinical trials, “more, more, more is not always better,” said [Michelle] Tregear, director of education and training programs for patient advocates at the National Breast Cancer Coalition, Washington, DC. “Industry interests are not always aligned with patient interests,” and “the system, by and large, is not addressing questions that really matter to patients and their families.”
